rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2011-6-10
|
pubmed:abstractText |
It has been reported that drug-eluting stents (DES) were superior to intracoronary brachytherapy (ICBT) in patients with in-stent restenosis (ISR). However, it is unknown whether there might be differences between DES and ICBT in terms of efficacy and safety in large sample size and long-term follow-up.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1932-8737
|
pubmed:author |
|
pubmed:copyrightInfo |
© 2011 Wiley Periodicals, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
344-51
|
pubmed:meshHeading |
pubmed-meshheading:21538389-Aged,
pubmed-meshheading:21538389-Angioplasty, Balloon, Coronary,
pubmed-meshheading:21538389-Brachytherapy,
pubmed-meshheading:21538389-Chi-Square Distribution,
pubmed-meshheading:21538389-Coronary Restenosis,
pubmed-meshheading:21538389-Coronary Stenosis,
pubmed-meshheading:21538389-Coronary Thrombosis,
pubmed-meshheading:21538389-Drug-Eluting Stents,
pubmed-meshheading:21538389-Female,
pubmed-meshheading:21538389-Humans,
pubmed-meshheading:21538389-Male,
pubmed-meshheading:21538389-Middle Aged,
pubmed-meshheading:21538389-Myocardial Infarction,
pubmed-meshheading:21538389-Odds Ratio,
pubmed-meshheading:21538389-Prosthesis Design,
pubmed-meshheading:21538389-Risk Assessment,
pubmed-meshheading:21538389-Risk Factors,
pubmed-meshheading:21538389-Time Factors,
pubmed-meshheading:21538389-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Drug-eluting stents vs. intracoronary brachytherapy for in-stent restenosis: a meta-analysis.
|
pubmed:affiliation |
Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
|
pubmed:publicationType |
Journal Article,
Review,
Meta-Analysis
|